153 related articles for article (PubMed ID: 30573562)
1.
Kato K; Miya F; Hamada N; Negishi Y; Narumi-Kishimoto Y; Ozawa H; Ito H; Hori I; Hattori A; Okamoto N; Kato M; Tsunoda T; Kanemura Y; Kosaki K; Takahashi Y; Nagata KI; Saitoh S
J Med Genet; 2019 Jun; 56(6):388-395. PubMed ID: 30573562
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function MYCN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome.
Nishio Y; Kato K; Tran Mau-Them F; Futagawa H; Quélin C; Masuda S; Vitobello A; Otsuji S; Shawki HH; Oishi H; Thauvin-Robinet C; Takenouchi T; Kosaki K; Takahashi Y; Saitoh S
HGG Adv; 2023 Oct; 4(4):100238. PubMed ID: 37710961
[TBL] [Abstract][Full Text] [Related]
3. Maternal mosaicism underlies the inheritance of a rare germline AKT3 variant which is responsible for megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome in two Roma half-siblings.
Szalai R; Melegh BI; Till A; Ripszam R; Csabi G; Acharya A; Schrauwen I; Leal SM; Komoly S; Kosztolanyi G; Hadzsiev K
Exp Mol Pathol; 2020 Aug; 115():104471. PubMed ID: 32446860
[TBL] [Abstract][Full Text] [Related]
4. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
Mirzaa G; Parry DA; Fry AE; Giamanco KA; Schwartzentruber J; Vanstone M; Logan CV; Roberts N; Johnson CA; Singh S; Kholmanskikh SS; Adams C; Hodge RD; Hevner RF; Bonthron DT; Braun KPJ; Faivre L; Rivière JB; St-Onge J; Gripp KW; Mancini GM; Pang K; Sweeney E; van Esch H; Verbeek N; Wieczorek D; Steinraths M; Majewski J; ; Boycot KM; Pilz DT; Ross ME; Dobyns WB; Sheridan EG
Nat Genet; 2014 May; 46(5):510-515. PubMed ID: 24705253
[TBL] [Abstract][Full Text] [Related]
5. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
Pirozzi F; Lee B; Horsley N; Burkardt DD; Dobyns WB; Graham JM; Dentici ML; Cesario C; Schallner J; Porrmann J; Di Donato N; Sanchez-Lara PA; Mirzaa GM
Am J Med Genet A; 2021 Sep; 185(9):2719-2738. PubMed ID: 34087052
[TBL] [Abstract][Full Text] [Related]
6. Recurrent mosaic MTOR c.5930C > T (p.Thr1977Ile) variant causing megalencephaly, asymmetric polymicrogyria, and cutaneous pigmentary mosaicism: Case report and review of the literature.
Handoko M; Emrick LT; Rosenfeld JA; Wang X; Tran AA; Turner A; Belmont JW; ; Lee BH; Bacino CA; Chao HT
Am J Med Genet A; 2019 Mar; 179(3):475-479. PubMed ID: 30569621
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1.
Peleg A; Kurolap A; Sagi-Dain L; Larom-Khan G; Adir V; Mory A; Paperna T; Shuldiner AR; Gonzaga-Jauregui C; Adir N; Baris Feldman H; Wollstein R
Clin Dysmorphol; 2021 Apr; 30(2):71-75. PubMed ID: 32925198
[TBL] [Abstract][Full Text] [Related]
8. Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE).
Bi W; Glass IA; Muzny DM; Gibbs RA; Eng CM; Yang Y; Sun A
Am J Med Genet A; 2016 Aug; 170(8):2181-5. PubMed ID: 27170158
[TBL] [Abstract][Full Text] [Related]
9. A
Zhao MF; Zhang SL; Xiang Y; Wang Q; Cao GH; Zhang PP; Fan LL; Yu R; Li YL
DNA Cell Biol; 2024 May; ():. PubMed ID: 38700464
[TBL] [Abstract][Full Text] [Related]
10. Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.
Tapper WJ; Foulds N; Cross NC; Aranaz P; Score J; Hidalgo-Curtis C; Robinson DO; Gibson J; Ennis S; Temple IK; Collins A
PLoS One; 2014; 9(1):e86940. PubMed ID: 24497998
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype.
Tedesco MG; Lonardo F; Ceccarini C; Cesarano C; Digilio MC; Magliozzi M; Rogaia D; Mencarelli A; Leoni C; Piscopo C; Imperatore V; Falco MT; Fontana P; Nardone AM; Novelli A; Troiani S; Seri M; Prontera P
Am J Med Genet A; 2021 Apr; 185(4):1204-1210. PubMed ID: 33442900
[TBL] [Abstract][Full Text] [Related]
12. Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?
Döcker D; Schubach M; Menzel M; Spaich C; Gabriel HD; Zenker M; Bartholdi D; Biskup S
Eur J Hum Genet; 2015 Mar; 23(3):409-12. PubMed ID: 24939587
[TBL] [Abstract][Full Text] [Related]
13. Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
Alcantara D; Timms AE; Gripp K; Baker L; Park K; Collins S; Cheng C; Stewart F; Mehta SG; Saggar A; Sztriha L; Zombor M; Caluseriu O; Mesterman R; Van Allen MI; Jacquinet A; Ygberg S; Bernstein JA; Wenger AM; Guturu H; Bejerano G; Gomez-Ospina N; Lehman A; Alfei E; Pantaleoni C; Conti V; Guerrini R; Moog U; Graham JM; Hevner R; Dobyns WB; O'Driscoll M; Mirzaa GM
Brain; 2017 Oct; 140(10):2610-2622. PubMed ID: 28969385
[TBL] [Abstract][Full Text] [Related]
14. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
Rivière JB; Mirzaa GM; O'Roak BJ; Beddaoui M; Alcantara D; Conway RL; St-Onge J; Schwartzentruber JA; Gripp KW; Nikkel SM; Worthylake T; Sullivan CT; Ward TR; Butler HE; Kramer NA; Albrecht B; Armour CM; Armstrong L; Caluseriu O; Cytrynbaum C; Drolet BA; Innes AM; Lauzon JL; Lin AE; Mancini GM; Meschino WS; Reggin JD; Saggar AK; Lerman-Sagie T; Uyanik G; Weksberg R; Zirn B; Beaulieu CL; ; Majewski J; Bulman DE; O'Driscoll M; Shendure J; Graham JM; Boycott KM; Dobyns WB
Nat Genet; 2012 Jun; 44(8):934-40. PubMed ID: 22729224
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-function variants in the ODC1 gene cause a syndromic neurodevelopmental disorder associated with macrocephaly, alopecia, dysmorphic features, and neuroimaging abnormalities.
Rodan LH; Anyane-Yeboa K; Chong K; Klein Wassink-Ruiter JS; Wilson A; Smith L; Kothare SV; Rajabi F; Blaser S; Ni M; DeBerardinis RJ; Poduri A; Berry GT
Am J Med Genet A; 2018 Dec; 176(12):2554-2560. PubMed ID: 30475435
[TBL] [Abstract][Full Text] [Related]
16. Prenatal Ultrasound Diagnosis of Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome with Persistent Hyperplastic Primary Vitreous: A Case Report.
Su XR; Ma B; Zhang C; Li TG; Han BL; Wu WR; Nie F
Fetal Diagn Ther; 2024; 51(2):154-158. PubMed ID: 38008077
[TBL] [Abstract][Full Text] [Related]
17. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.
Mirzaa GM; Rivière JB; Dobyns WB
Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):122-30. PubMed ID: 23592320
[TBL] [Abstract][Full Text] [Related]
18. A novel de novo germline mutation Glu40Lys in AKT3 causes megalencephaly with growth hormone deficiency.
Takagi M; Dobashi K; Nagahara K; Kato M; Nishimura G; Fukuzawa R; Narumi S; Hasegawa T
Am J Med Genet A; 2017 Apr; 173(4):1071-1076. PubMed ID: 28190287
[TBL] [Abstract][Full Text] [Related]
19. Delineating the Smith-Kingsmore syndrome phenotype: Investigation of 16 patients with the MTOR c.5395G > A p.(Glu1799Lys) missense variant.
Poole RL; Curry PDK; Marcinkute R; Brewer C; Coman D; Hobson E; Johnson D; Lynch SA; Saggar A; Searle C; Scurr I; Turnpenny PD; Vasudevan P; Tatton-Brown K
Am J Med Genet A; 2021 Aug; 185(8):2445-2454. PubMed ID: 34032352
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
